Uncategorised – Page 36 – Market Industry Forecast News

Disposable Endoscopes Market: North America Dominated and Accounted For The Highest Revenue Share

Disposable Endoscopes Industry Overview

The global disposable endoscopes market size was valued at USD 1.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 17.0% from 2022 to 2030. The growing cross-contamination issue of reusable endoscopes is one of the major factors expected to drive market growth. In 2020, Mr. Brian Dunkin MD, CMO of Boston Scientific Endoscopy stated that one in 20 patients has a pathogen contamination concern. Moreover, several tedious sterilization steps to eliminate all kinds of microorganisms from the reusable endoscopes are also expected to increase the adoption of disposable endoscopes.

For instance, according to Boston Scientific, cleaning of endoscopes during ERCP procedures requires over 100 series of manual steps to reuse and it’s also vulnerable to error. Furthermore, the increasing preference of medical professionals to use single-use or disposable endoscopic devices is supporting the market growth. For instance, The Centers for Medicare & Medicaid Services (CMS) 2020 has released a new device passcode for single-use endoscopes. Hospitals and Ambulatory Surgical Centers (ASCs) use this code for treating Medicare patients in the U.S. using single-use duodenoscopes.

Gather more insights about the market drivers, restrains and growth of the Global Disposable Endoscopes market

A moderate impact has been observed during the COVID-19 outbreak on the disposable endoscope market growth. The decrease in the number of surgical procedures due to the COVID-19 pandemic also hampered product adoption. In addition, the shortage of medical staff due to the increased infection risks associated with the cleaning of endoscopes also increase the adoption of single-use devices during the COVID-19 pandemic. For instance, according to a study reported in the Journal of Bronchology & Interventional Pulmonology in 2021, in the U.S., about 11% of health workers were infected with COVID-19 and in Italy, the percentage is approximately 20%.

However, the demand for single-use endoscopes is expected to increase with the gradual depart of COVID-19 due to its safety and elimination of the possibilities of infection. Furthermore, single-use devices are more cost-effective than reusable ones, which is expected to drive market growth. For instance, according to the data published by the Association of Anesthetics in November 2019, the mean cost per patient for reusable flexible bronchoscopes is £511.00 with an associated risk of infection of 2.8%. The estimated mean cost of single-use flexible bronchoscopes per patient is £220.00 and a 0% risk of infection.

Similarly, in 2019, a study published in Chest Journal reported that reusable bronchoscopes used by hospitals are paying about 21% to 155% more per instrument as compared to disposable endoscopes. Consequently, the cost-effectiveness, lower chances of cross-contamination, and minimum resource utilization are in turn expected to propel the market growth over the forecast years. Rapid technological advancements coupled with the growing investments by key manufacturers to develop new, innovative products are anticipated to drive the market further. For instance, in May 2020, Ambu A/S, a single-use endoscope manufacturer, launched Ambu aView 2 Advance, a display unit for single-use endoscopes.

This product is a mobile platform and can be used in different types of endoscopic devices including rhinolaryngoscope, bronchoscope, and cystoscopes among others. Omnivision, in November 2020, introduced imaging subsystems including image signal processor boards, camera modules, and cables for disposable endoscopic devices. Moreover, in November 2020, Olympus Corporation made partnerships with Ruhof Corporation and launched single-use procedure kits and hybrid tubing for endoscopes to reduce infection risks. Thus, the development of visualization systems and components for re-usable endoscopes is supporting the market growth.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

Pelvic Floor Electric Stimulator Market – The global pelvic floor electric stimulator market size was valued at USD 180.92 million in 2020. It is expected to expand at a compound annual growth rate (CAGR) of 11.5% from 2021 to 2028 to reach USD 427.15 million by 2028.
Brachytherapy Market – The global brachytherapy market size was valued at USD 788.5 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.1% from 2021 to 2028.

Disposable Endoscopes Market Segmentation

Grand View Research has segmented the global disposable endoscopes market on the basis of application, end-use, and region:

Disposable Endoscopes Application Outlook (Revenue, USD Million, 2014 – 2030)

Bronchoscopy
Urologic Endoscopy
Arthroscopy
GI Endoscopy
ENT Endoscopy
Others

Disposable Endoscopes End-use Outlook (Revenue, USD Million, 2014 – 2030)

Hospitals
Clinics
Diagnostics Centers

Disposable Endoscopes Regional Outlook (Revenue, USD Million, 2014 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

February 2019: Zsquare, an Israeli endoscopy firm, received USD 10 million for the development of a single-use endoscopic platform multiply.
December 2019: introduced single-use Duodenoscope “EXALT Model D” for ERCP (endoscopic retrograde cholangiopancreatography) procedures.

Key Companies profiled:
Some of the prominent players in the global disposable endoscopes market include:

Ambu A/S
Prosurg Inc. (Neoscape, Inc.)
Boston Scientific Corp.
Parburch Medical
OBP Medical Corp.
Welch Allyn (Hill-Rom Services Inc.)
Flexicare Medical Ltd.
Timesco Healthcare Ltd.
Sunmed

Order a free sample PDF of the Disposable Endoscopes Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Clinical Trial Imaging Market: North America Dominated With Revenue Share

Clinical Trial Imaging Industry Overview

The global clinical trial imaging market size was estimated at USD 851.8 million in 2021and is expected to expand at a compound annual growth rate (CAGR) of 8.7% from 2022 to 2030. Mounting biotechnology and pharmaceutical industries combined with increased research and development investments for developing new drugs to treat diseases is expected to drive the market industry growth. Medical imaging plays an active role in the clinical development of novel life science products. Although the medical imaging industry is in a constant state of fluctuation, the biotechnology, and pharmaceutical industries continue to increase. This can be attributed to the enhanced investment in medical imaging companies and mergers and acquisitions, supported by the adoption of innovative imaging technologies to support clinical trials for medical devices.

However, the high cost of machinery and their installations, and the enormous cost of clinical trials may limit the market growth during the forecast period. Advancements in technology are bringing substantial improvements to the collection, evaluation, and submit clinical trial imaging data. Technology-enabled imaging, especially image analysis software, provides various benefits to clinical studies such as consistency, data accuracy, adaptability as well as compliance. For instance, image analysis software is used to direct and manage a reader via analysis of imaging time points.

Gather more insights about the market drivers, restrains and growth of the Global Clinical Trial Imaging market

The outbreak of COVID-19 has adversely impacted the healthcare system in most countries, leading to a disruption in medical studies, research activities, and reduced sponsorship for research involving clinical trials. The pandemic has hampered the clinical trial timeline as numerous ongoing studies were delayed and planned studies were canceled. Unfavorable changes in regulations and guidelines, supply chain disruption, recruitment challenges for clinical trials, fear of viral spread, and shutting down of most manufacturers during lockdown have also adversely impacted the market. However, the introduction of virtual imaging trials during the COVID-19 pandemic is expected to open new avenues for the adoption of these devices. The development of advanced computational models helps has helped in better assessment of CT and radiography images which are expected to help in the early diagnosis of COVID-19 in patients. The clinical trial imaging market is said to bounce back by 2022 Q2, supported by the rise in R&D activities and improvement in supply and distribution channels.

Increased use of imaging technology along with the enhanced power of computing is expected to drive the usage of imaging in clinical trials. The Quantitative Imaging Biomarkers Alliance (QIBA) protocol has come up with standardized methods and imaging procedures with uniform procedures to be implemented for attaining statistical and precise endpoints in clinical trials.

For improving image assessment and capturing, numerous technology patents have been filed. Also, patented technologies are being provided by the imaging core lab players that are expected to aid the pharmaceutical companies in minimizing development timelines. For instance, a reading tool named Assessa, by IXICO aids in improved decision-making in clinical trials for diseases associated with memories such as schizophrenia, Parkinson’s, and Alzheimer’s disease, and neurological disorders like dementia and cognitive impairment.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

Hospital Acquired Infection Control Market – The global hospital acquired infection control market size was valued at USD 5.5 billion in 2020 and is estimated to expand at a compound annual growth rate (CAGR) of 4.9% from 2021 to 2028.
Medical Equipment Calibration Services Market – The global medical equipment calibration services market size was valued at USD 1.0 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 9.4% from 2021 to 2028.

Clinical Trial Imaging Market Segmentation

Grand View Research has segmented the global clinical trial imaging market based on service, application, end-use, and region:

Clinical Trial Imaging Service Outlook (Revenue, USD Million, 2018 – 2030)

Clinical Trial Design and Consultation Services
Reading and Analytical Services
Operational Imaging Services
System and Technology Support Services
Project and Data Management

Clinical Trial Imaging Application Outlook (Revenue, USD Million, 2018 – 2030)

NASH
CKD
Diabetes
Cardiovascular Diseases
Musculoskeletal
Oncology
Gastroenterology
Pediatrics
Others

Clinical Trial Imaging End-use Outlook (Revenue, USD Million, 2018 – 2030)

Biotechnology and Pharmaceutical companies
Medical Devices Manufacturers
Academic and Government Research Institutes
Contract Research Organizations (CROs)
Others

Clinical Trial Imaging Regional Outlook (Revenue, USD Million, 2018 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

February 2020: ICON plc acquired MedPass International, a European medical devices CRO, reimbursement, and regulatory consultancy. This acquisition has reportedly helped in the expansion of the medical device and diagnostic research services of ICON in Europe.
June 2018: Bioclinica introduced the SMART technology suite available with Medical Imaging, Interactive Response Technology (IRT), and Electronic Data Capture (EDC) to submit, manage, investigate, report & transfer medical image data compliant with universal data privacy and global requirements.

Key Companies profiled:

Some of the prominent players in the global clinical trial imaging market include:

IXICO plc
Navitas Life Sciences
Resonance Health
ProScan Imaging
Radiant Sage LLC
Medpace
Biomedical Systems Corp
Cardiovascular Imaging Technologies
Intrinsic Imaging
BioTelemetry

Order a free sample PDF of the Clinical Trial Imaging Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Next-Generation Sequencing Services Market: U.S. Is Anticipated To Drive The Regional Growth By 2030

Next-Generation Sequencing Services Industry Overview

The global next-generation sequencing services market size was valued at USD 1.03 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 18.3% from 2022 to 2030. Next-generation sequencing (NGS) technology is increasingly leveraged for both conventional and non-conventional applications to gain rapid and comprehensive insights at a genomic level. This is primarily due to continuous improvements in automation, ancillary protocols, services, and analytical solutions in this field. This, in turn, has provided healthy growth prospects for the implementation of NGS in clinical workflows.

Growing demand for robust sequencing-based diagnostics has resulted in the inception of new seq-technologies, ranging from high-throughput sequencers to portable units. This has fomented the trend of clinical NGS in recent times. For example, in March 2022, ARUP Laboratories declared the launch of new coronavirus tests, and IDbyDNA, Inc. collaborated with another firm introducing new tests for coronavirus, an NGS test for respiratory infections, to assist physicians in screening patients with pneumonia and other respiratory diseases.

Gather more insights about the market drivers, restrains and growth of the Global Next-Generation Sequencing Services market

The market leader, Illumina, has launched the Illumina Propel Certification Program (CSPro) to establish a partnership between the company and laboratories. In July 2019, GENEWIZ scientists are committed to assisting in identifying the NGS solution for the projects. The NeXT Dx Test was launched by Personalis, Inc. to assist oncologists in identifying new therapy and clinical trial choices for people with cancer. The Personalis NeXT Dx Check is among the first cancer diagnostic platforms to profile nearly 20,000 genes in both the tumor exome and transcriptome, offering a complete genomic result in great that goes beyond existing cancer diagnosing panels that focus on a few dozen genes. Advanced analytics are included in the Personalis NeXT Dx Test, which provides a diagnostic report on genetic changes in medically essential cancer genes and emerging immunotherapy synthesis biomarkers of medical value. The clinical report also includes immunotherapy-related indicators such as microsatellite instability (MSI) status and tumor mutational burden (TMB) in January 2020.

Most service providers employ platforms from Illumina, PacBio, and Oxford Nanopore Technologies. They use these technologies in-house to serve their customers by delivering projects with high quality and within the shortest timelines. There are also some products that are no longer commercially available, such as products from 454 Life Sciences.

Some products are still under development, such as the SOLiD platform and Ion Torrent’s semiconductor sequencing. However, these products are not as widely accepted as those offered by Illumina. Data generated through genome sequencing is considered an efficient diagnostic and prognostic tool to aid clinicians in identifying specific characteristics in each patient. This, in turn, helps in offering personalized therapies to patients, thus improving patient outcomes. This factor is anticipated to fuel the demand for NGS-based diagnostics in the coming years.

Next-generation sequencing is an effective and impartial technique to recognize new coronavirus variants and other pathogens without foreknowledge of the organism. Sequencing allowed the globe to promptly recognize SARS-CoV-2 and advance diagnostic tests and extra tools for epidemic management. Continued genomic sequencing holdup the tracking of the disease’s spread and evolution of the virus. Hastened integration of genomic sequencing in the direction of the exercise of the global health community is essential to prepare for future threats.

Some of the major issues faced by end-users in the market are implementing large-scale data analysis and analytical challenges while conducting single-cell sequencing. Nevertheless, manufacturers are constantly strategizing their R&D in order to address these challenges and augment the scope of NGS services.

SARS-CoV-2 generates a wide range of clinical symptoms, from mild to severe. In order to be effective, disease management and prevention strategies must account for all kinds of transmission, including asymptomatic and presymptomatic individuals. Other infections may also impact the development of Covid-19; having awareness of these could help identify individuals who are at a higher risk of developing severe sickness. Illumina has developed two approaches for decoding SARS-CoV-2 from samples collected to aid researchers in their efforts: one focused on shotgun metagenomics and the other on target enrichment.

Browse through Grand View Research’s Biotechnology Industry Research Reports.

Scaffold Technology Market – The global scaffold technology market size was valued at USD 1.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 8.4% from 2021 to 2028.
Spectrometry Market – The global spectrometry market size was estimated at USD 14.1 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.2% from 2021 to 2028.

Next-generation Sequencing Services Market Segmentation

Grand View Research has segmented the global next-generation sequencing services market on the basis of service type, workflow, end-use, and region:

NGS Service Type Outlook (Revenue, USD Million, 2017 – 2030)

Human Genome Sequencing
Single Cell Sequencing
Microbial Genome-based Sequencing
Gene Regulation Services
Animal & Plant Sequencing
Other Sequencing Services

NGS Services Workflow Outlook (Revenue, USD Million, 2017 – 2030)

Pre-sequencing
Sequencing
Data Analysis

NGS Services End-use Outlook (Revenue, USD Million, 2017 – 2030)

Universities & Other Research Entities
Hospitals & Clinics
Pharma & Biotech Entities
Others

NGS Services Regional Outlook (Revenue, USD Million, 2017 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

November 2021: Illumina and Genetic Alliance announced iHope Genetic Program aspires to provide WGS (whole-genome sequencing) access to thousands of people suffering from genetic illness around the world.

Key Companies profiled:
Some prominent players in the global next-generation sequencing services market include:

Illumina, Inc.
Veritas Genetics
BGI
GENEWIZ Germany GmbH
ABM Inc.
ARUP Laboratories
Novogene Corporation
Lucigen
Quest Diagnostics
Gene by Gene

Order a free sample PDF of the Next-Generation Sequencing Services Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Legal Marijuana Market: Medical Segment Accounted For The Largest Revenue Share

Legal Marijuana Industry Overview

The global legal marijuana market size was valued at USD 16.7 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 25.4% from 2023 to 2030. The growing demand for legal marijuana has been a primary factor in the growth of the market. Recently, a large number of countries have legalized the use of medical marijuana for treating various ailments. A number of studies carried out show that medical marijuana and its derivatives can be used to treat symptoms of various diseases, for e.g., it has been successfully used to treat patients with chronic pain, chemotherapy-induced nausea, Parkinson’s, Alzheimer’s, and other neurological diseases. The FDA and other such associations have now started accepting the marijuana derivatives for the prescription of diseases in which it has proven to be useful. This is another factor for the quick turnaround of its legal status in a lot of countries. North America (the U.S. and Canada) has gone a step further and has sanctioned the use of recreational marijuana as well and more than two-thirds of the U.S. states have legalized marijuana.

Gather more insights about the market drivers, restrains and growth of the Global Legal Marijuana market

The pandemic severely affected the logistics network for cannabis and its derivatives and due to the ongoing restrictions, the government authorized dispensaries are also facing shortages owing to disruption in the supply chain network. Import and export of nearly all commodities essential or not have been affected as well. However, with the governments endorsing legalization, the demand has risen and is likely to be high in the next few years. Patients are opting for marijuana derivatives instead of the prescription medicines previously being used.

With the government policies changing, the demand for medical marijuana is also rising. A lot of countries that have legalized the use of medical marijuana are also paving way for its cultivation to cut on the imports and gain revenue in the form of taxes. This, in turn, has generated jobs in the industry and a lot more companies are dabbling in this territory. Several startups in the U.S. and Europe are now focusing on alternate uses of cannabis, other than recreational and medicinal. With so much happening in and around the cannabis industries, the countries are paving way for more liberal policies regarding its cultivation and usage in the medical field as well as industrial use.

The U.S. is seeing a growing number of cultivators for cannabis, including marijuana since this rakes in more revenues for the government and also cuts down on the cost of import. It has a myriad of applications from medical to industrial and since its legalization, the rise in its sale has been exponential and this has generated new opportunities to increase revenues. With the FDA-level authorizations underway, the market for legal marijuana is only going to expand. A large number of clinical trials will support the prowess of marijuana derivatives for it to be legally prescribed for indications.

Browse through Grand View Research’s Pharmaceuticals Industry Research Reports.

Gabapentin Market – Gabapentin belongs to class of anticonvulsants. The medication is prescribed for the control of seizures in the treatment of epilepsy. According to WHO, nearly 5 million individuals worldwide suffer from epilepsy, a persistent brain disorder.
Uterine Fibroid Treatment Drugs Market – Uterine fibroid (UF) are the most common benign tumors in women of childbearing age and the world is witnessing rise in prevalence of disease in women which is the key factor driving the market.

Legal Marijuana Market Segmentation

Grand View Research has segmented the global legal marijuana market based on product type, application, and region:

Legal Marijuana Product Type Outlook (Revenue, USD Million, 2016 – 2030)

Flower
Oil and Tinctures

Legal Marijuana Application Outlook (Revenue, USD Million, 2016 – 2030)

Medical
- Cancer
- Chronic Pain
- Depression and Anxiety
- Arthritis
- Diabetes
- Glaucoma
- Migraines
- Epilepsy
- Multiple Sclerosis
- AIDS
- Amyotrophic Lateral Sclerosis
- Alzheimer’s
- Post-traumatic Stress Disorder (PTSD)
- Parkinson’s
- Tourette’s
- Others
Adult Use

Legal Marijuana Regional Outlook (Revenue, USD Million, 2016 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Key Companies profiled:

Some prominent players in the global legal marijuana market include:

Canopy Growth Corporation
Aurora Cannabis
Aphria, Inc.
Tilray
ABcann Medicinals, Inc.
The Cronos Group
Maricann Group, Inc.
Organigram Holding, Inc.
Lexaria Corp.
GW Pharmaceuticals
United Cannabis Corporation
Tikun Olam, Ltd.

Order a free sample PDF of the Legal Marijuana Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Anastomosis Devices Market: Asia Pacific (APAC) Is Likely To Register The Highest CAGR Over The Forecast Period

Anastomosis Devices Industry Overview

The global anastomosis devices market size was valued at USD 3.58 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.6% from 2022 to 2030. Rising surgical procedures along with the growing prevalence of cardiovascular and gastrointestinal diseases are the key trends escalating market growth. The surgical practice has been considerably impacted by the outbreak of COVID-19. The pandemic has created challenges for general surgery practice. It has had ramifications for ways of working, open vs minimally invasive, surgical techniques, patient and staff safety, theatre workflow, training, and education. All specialisms have had to triage the importance of their regular surgical procedures and think about non-surgical management options where possible. Many elective or semi-elective procedures including gastrointestinal malignancies have been suspended. However, the market will witness the demand after the commencement of these surgeries at full force.

Moreover, the demand for improved patient outcomes will drive the uptake of novel innovations in anastomosis devices and contributes to market growth. For instance, in December 2020, India Medtronic Private Limited, a wholly-owned subsidiary of Medtronic introduced EEA Circular Stapler with Tri-Staple Technology. This is the first 3-row Circular Stapler with wide-ranging height staples is indicated for use in colorectal procedures.

Gather more insights about the market drivers, restrains and growth of the Global Anastomosis Devices market

The introduction of technologically-advanced products and favorable reimbursement scenarios in cardiac procedures, which comprises Coronary Bypass Graft Surgery (CABG), open-heart valve replacement, and angioplasty in developed countries are boosting the growth of the market for anastomosis devices. For instance, Medicare Part B covers coronary artery bypass graft surgery, coronary angioplasty, valve repair & replacement, and other comprehensive Cardiac Rehabilitation (CR) programs.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

Assisted Walking Devices Market – The global assisted walking devices market size was valued at USD 3.4 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 6.6% during the forecast period.
Perfusion System Market – The global perfusion system market size was valued at USD 1.02 billion in 2021 and is anticipated to expand at a compound annual growth rate (CAGR) of 4.7% from 2022 to 2030.

Anastomosis Devices Market Segmentation

Grand View Research has segmented the global anastomosis devices market based on product type, application, end-user, and region:

Anastomosis Devices Product Type Outlook (Revenue, USD Million, 2017 – 2030)

Disposable
Reusable

Anastomosis Devices Application Outlook (Revenue, USD Million, 2017 – 2030)

Cardiovascular Surgery
Gastrointestinal Surgery
Others

Anastomosis Devices End-user Outlook (Revenue, USD Million, 2017 – 2030)

Hospitals
Ambulatory Care Center & Clinics

Anastomosis Devices Regional Outlook (Revenue, USD Million, 2017 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

March 2021: Vascular Graft Solutions Ltd. received a receipt of marketing authorization from the FDA for the VIOLA. This is a new device for clampless proximal anastomosis in CABG.

Key Companies profiled:

Some of the prominent players operating in the global anastomosis devices market are:

Medtronic
LivaNova PLC
MAQUET Holding B.V. & Co. KG.
Dextera Surgical Inc.
Vitalitec Internaional Inc.
Synovis Micro Companies Alliance, Inc.
Ethicon US, LLC
Peters Surgical

Order a free sample PDF of the Anastomosis Devices Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Neglected Tropical Diseases Diagnosis Market Size, Share & Trends Analysis Report 2022-2030

Neglected Tropical Diseases Diagnosis Industry Overview

The global neglected tropical diseases (NTD) diagnosis market size was valued at USD 6.09 billion in 2021 and is expected to expand at a CAGR of 4.4% during the forecast period. Growing awareness of NTDs and an increasing number of initiatives undertaken by the government are anticipated to fuel the market growth. For instance, the inclusion of NTDs in the Sustainable Development Goals (SDG), a United Nations Development Program, as a global target is anticipated to fuel market growth. Furthermore, various initiatives being undertaken by WHO, such as road map 2030 for the elimination of NTDs, are expected to drive market growth during the forecast period.

In the wake of the COVID-19 pandemic, the neglected tropical disease (NTD) diagnosis witnessed a significant decline. WHO launched the Global Program to Eliminate Lymphatic Filariasis (GPELF) in 2000, which aims to stop the spread of the infection and relieve the pain of those who have already been afflicted. However, according to the pulse survey conducted by WHO, as of early 2021, the neglected tropical disease program has faced disruptions in 44% of countries. Moreover, the high risk of transmission of SARS-CoV-2 infection has affected the public health approaches for NTDs. In countries with low health budgets, funds being shifted to tackle other diseases, and a shortage of funding from international partners and the foreign government has significantly impacted the growth of the market.

Gather more insights about the market drivers, restrains and growth of the Global Neglected Tropical Diseases Diagnosis market

The NTD program has expanded its support to 31 countries in Asia, Latin America, and Africa. Besides, it has provided more than 2.6 billion treatments and leveraged more than USD 22.3 billion in donated medicines. Government organizations such as CDC and WHO collaborate with counties to improve existing public health services for NTDs. Moreover, in January 2021, the WHO introduced its roadmap for NTDs for the period 2021 to 2030. It is aimed to increase the prevention and control of neglected tropical diseases worldwide. Such initiatives undertaken by the government bodies are anticipated to drive the market growth during the forecast period.

Globally, several organizations initiated multiple programs, which contribute to rising in the awareness of NTDs, including the Global NTD Program by the Centers for Disease Control and Prevention, Global NTD Programs by the World Health Organization, NTD Program by the United States Agency for International Development, the United States Global Health Initiative. The primary focus of all these programs is on controlling or eliminating NTDs. Similarly, the London Declaration was initiated to sustain, expand, and extend different programs to support & control guinea worm disease, leprosy, lymphatic filariasis, sleeping sickness, trachoma, schistosomiasis, and Chagas disease by 2020.

The increasing burden of NTDs is considered to be a major factor fueling the growth of the overall market during the forecast period. According to WHO estimates, more than 1.7 billion individuals, about one-fifth of the world’s population, mostly in lower-income and developing countries-required interventions for at least one NTD every year. Around 40% of the African region was affected by NTDs. These diseases are more prevalent among the poor population living in tropical environments and difficult-to-access areas. Countries such as Brazil, Yemen, India, Bangladesh, China, and some countries in Central & East Africa contribute the majority of NTD cases globally.

Browse through Grand View Research’s Clinical Diagnostics Industry Research Reports.

DNA Microarray Market – DNA microarray is a biotechnology tool used to detect changes in gene expression levels by analyzing a small sample of DNA to study the expression of thousands of genes simultaneously. This technique uses a DNA sample to create a “probe” that is placed on a glass slide containing different gene sequences.
ELISA Analyzers Market – ELISA (Enzyme-Linked Immunosorbent Assay) is a widely used diagnostic tool that allows for the detection and measurement of specific proteins and antibodies in a sample. ELISA analyzers, which are automated instruments that perform various steps of the assay, provide accurate and reproducible results.

Neglected Tropical Disease Diagnosis Market Segmentation

Grand View Research has segmented the neglected tropical disease diagnosis market based on disease, diagnostic method, service type, end-use, and region:

Disease Outlook (Revenue, USD Million, 2014 – 2025)

Dengue
Chikungunya
Rabies
Leprosy
Buruli Ulcer
Yaws
Lymphatic Filariasis
Taeniasis/Cysticercosis
Foodborne Trematodiases
Echinococcosis
Chagas Disease (American Trypanosomiasis)
Dracunculiasis
African Trypanosomiasis
Soil-transmitted Helminth Infections
Onchocerciasis
Schistosomiasis
Scabies and Other Ectoparasites
Snakebite Envenoming
Leishmaniasis

Diagnosis Diagnostic Method Outlook (Revenue, USD Million, 2014 – 2025)

Conventional Method
Molecular/Modern Method

Service Type Outlook (Revenue, USD Million, 2014 – 2025)

Centralized Service
POC Service

End-use Outlook (Revenue, USD Million, 2014 – 2025)

Clinical Labs
Hospitals /Clinics
Home Healthcare

Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

March 2021: EUROIMMUN launched the EUROPatternTM Microscope Live (EPML) compact immunofluorescence microscope used to detect antibodies in the sample and enhance the quality of indirect immunofluorescence testing.

Key Companies profiled:

Some of the key players in the global neglected tropical disease diagnosis market include:

F. Hoffmann-La Roche Ltd
Abbott
Thermo Fisher Scientific Inc.
ZeptoMetrix
InBios International, Inc.
Genome Diagnostics Pvt. Ltd.
Omega Diagnostics Group PLC
Coris BioConcept
DiaSys Diagnostic Systems GmbH
Oscar Medicare Pvt Ltd.

Order a free sample PDF of the Neglected Tropical Disease Diagnosis Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

U.S. Sexual Wellness Market: Personal Lubricants Segment Is Expected To Witness The Highest CAGR Of 10.53%

U.S. Sexual Wellness Industry Overview

The U.S. sexual wellness market size was valued at USD 10.3 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 7.67% from 2022 to 2030. The market is anticipated to exhibit lucrative growth in the coming years due to the rising prevalence of Sexually Transmitted Diseases (STDs) and HIV infection. Increasing government initiatives and NGOs participating in promoting the use of contraceptives is expected to boost the market growth. The increasing childbearing population of women in the U.S. and ease of online shopping and e-commerce are expected to further facilitate the sales of sexual wellness products. The NYC Health Department recommended masturbation as the safest form of sexual activity to minimize contact with others and reduce the spread of COVID-19.

Since the pandemic has reduced the stigma around masturbation, an increasing number of customers in the country are opting for various sex toys to improve their sexual experience. The stigma attached to sexual activities & experimenting is reducing due to liberalization and growing acceptance of homosexuality. Sex-positive movements have helped clear the stereotypes related to gender, age, and social construct of people. The banks and investors who were reluctant to fund ventures in sexual wellness products are now investing in this space.

Gather more insights about the market drivers, restrains and growth of the U.S. Sexual Wellness market

In recent times, the stereotypical perception has witnessed some change and angel investors are also increasingly investing with manufacturers. For instance, in March 2021, PLBY Group, Inc. spent USD 25 million to buy a TLA acquisition firm that sold sex toys through a subsidiary. Major brands in the U.S. market for sexual wellness are expected to witness lucrative demand due to the growing use of sex toys among both men and women.

U.S. government is also taking initiatives towards sexual wellness by promoting safe sex, further propelling the growth of the market. For instance, in June 2020, the New York health department started a home delivery service called “Door 2 Door” to promote the practice of safe sex. The service provides the delivery of condoms, lubricants, and HIV tests via an online platform.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

Contrast Media Market – The global contrast media market size was valued at USD 4.04 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 3.33% from 2022 to 2030.
Hearing Aids Market – The global hearing aids market size was valued at USD 10.1 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.9% from 2022 to 2030.

U.S. Sexual Wellness Market Segmentation

Grand View Research has segmented the U.S. sexual wellness market based on product, distribution channel and region:

U.S. Sexual Wellness Product Outlook (Revenue, USD Million, 2017 – 2030)

Sex Toys
- Vibrators
- Dildos
- Penis Rings
- Anal Toys
- Masturbation Sleeve
- Bondage
- Sex Dolls
- Others
Condoms
- Male Condoms
- Female Condoms
Personal Lubricants
- Water-based
- Silicone-based
- Oil-based

U.S. Sexual Wellness Distribution Channel Outlook (Revenue, USD Million, 2017 – 2030)

E-commerce
Retailers
Mass Merchandizers

Market Share Insights

August 2021: Wow Tech and Lovehoney announced a merger and the combined group will be led by Wow Tech with an aim of achieving new heights in sexual wellness.

Key Companies profiled:

Some of the prominent players in the U.S. sexual wellness market include:

Church & Dwight Co., Inc.
Reckitt Benckiser Group plc
Veru Inc.
Doc Johnson Enterprises
Mayer Laboratories, Inc.
LifeStyles Healthcare Pte Ltd
BioFilm, Inc.
LELO
Trigg Laboratories Inc.
Innovus Pharmaceuticals, Inc.
Unbound
CC Wellness

Order a free sample PDF of the U.S. Sexual Wellness Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Medical Tapes And Bandages Market: Ambulatory Surgery Centers Segment Captured The Second Largest Share

Medical Tapes And Bandages Industry Overview

The global medical tapes and bandages market size was valued at USD 9.05 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 3.41% from 2022 to 2030. The growth of the market is attributed to the increasing prevalence of chronic diseases such as diabetes, cancer, and other autoimmune diseases, the increasing number of road accidents, and technological advancements, coupled with the increasing adoption of medical tapes and bandages in various healthcare settings such as hospital, clinics, and others.

For instance, according to the 3M company in 2019, 69% of clinicians use medical tape multiple times per day which is expected to boost the market growth. During the outbreak of COVID-19 disease, face masks that are recommended to be used to prevent transmission of the infection can cause serious skin injuries, which may require several wound care products such as medical tapes, bandages, and others for treatment.

Thus, the COVID-19 pandemic has shown a positive impact on the market growth owing to its increased demand for critical care capacity and to support hospitals in the fight against COVID-19.

Gather more insights about the market drivers, restrains and growth of the Global Medical Tapes And Bandages market

Furthermore, according to the National Library of Medicine in September 2020, a barrier enclosure has been proposed for use during intubations where there is a substantial risk of aerosolization. The use of noninvasive respiratory assistance is on the rise amid the COVID-19 outbreak. However, it is linked to a significant risk of aerosol formation, which can lead to illnesses among healthcare workers (HCWs).

As a result, vacuum suction tubing was hooked to the wall mount, and the other end of the tubing was taped to the inside of the barrier enclosure’s roof with adhesive surgical tape. Thus, these adhesive surgical tapes offer protection against COVID-19-related illnesses in healthcare settings, which is expected to drive market growth. Due to the COVID-19 pandemic in 2020, sales of medical tapes and bandages increased significantly across the globe.

The global increase in the incidence of chronic diseases such as cancer, diabetes, and other autoimmune diseases is expected to drive market growth. Moreover, factors such as the adoption of unhealthy & sedentary lifestyles, antimicrobial resistance, smoking, and alcohol consumption are some of the other major factors contributing to the rise in the prevalence of non-communicable diseases. Furthermore, according to the WHO in April 2021, Non-communicable diseases (NCDs) claim the lives of 41 million people each year, accounting for 71% of all deaths worldwide.

In addition, cardiovascular illnesses kill 17.9 million people per year, followed by cancer (9.3 million), respiratory disorders (4.1 million), and diabetes (1.5 million). As a result of the rising prevalence of chronic conditions, the number of surgeries being performed has also increased which is anticipated to increase the demand for medical tapes and bandage products, propelling the market growth.

The market is predicted to grow during the forecast period due to an increase in the number of surgeries and trauma cases around the world. Trauma is a major cause of death worldwide, with around 5 million people dying every year as a result of traumatic injury. According to the Association for Safe International Road Travel (ASIRT) 2018, every year, between 20 million to 50 million individuals are injured or disabled in traffic accidents, with 1.35 million related deaths. According to the WHO, road traffic injuries are estimated to be the ninth leading cause of mortality globally.

Moreover, bandages and tapes are used for the treatment of minor wounds. Thus, the rising number of accidents is expected to boost the demand for medical tapes and bandages, which is expected to lead to considerable market growth over the forecast period.

Along with the aforementioned factors, the growing number of ambulatory surgery centers (ASCs) will propel market growth in the near future. According to the Texas Ambulatory Surgery Center Society, there will be over 5,344 surgery centers in the U.S. in 2021. Surgical treatment, diagnostics, and preventive procedures are among the services provided by ASCs. Ambulatory surgical centers also do pain management, urology, orthopedics, restorative, reconstructive, or alternative plastic procedures, and gastrointestinal (GI) surgeries.

Previously, ASCs could only do small GI surgeries; however, as the number of minimally invasive surgical procedures increased, the services provided by ambulatory surgery centers extended and developed exponentially. For instance, according to Agency for Healthcare Research and Quality in December 2021, the number of ambulatory procedures performed in community hospitals in the U.S. has steadily increased over the last quarter-century, rising from 13.4 million in 1995 to 19.2 million in 2018.

Technological advancements, coupled with product launches, to streamline the procedures and make them safer & more cost-effective, are among the key factors contributing to market growth. For instance, in May 2019, 3M entered into a definitive agreement to acquire the advanced wound care and specialty surgical solutions segments of Acelity and its KCI Subsidiaries, with an aim to expand the company’s product portfolio which is expected to boost the market growth in the near future.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

China Small Molecule CDMO Market – The China small molecule CDMO market size was valued at USD 11.0 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 19.4% from 2023 to 2030.
Continuous Glucose Monitoring Devices Market – The global continuous glucose monitoring devices market was estimated to be valued at USD 7,816.8 million in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4.4% from 2023 to 2030.

Medical Tapes And Bandages Market Segmentation

Grand View Research has segmented the global medical tapes and bandages market based on product, application, end-use, and regions:

Medical Tapes And Bandages, Product Outlook (Revenue USD Million, 2018 – 2030)

Medical Tapes
- Fabric Tapes
  - Acetate
  - Viscose
  - Cotton
  - Silk
  - Polyester
  - Other Fabric Tapes
- Paper Tapes
- Plastic Tapes
  - Polypropylene
  - Other Plastic Tapes
- Other Tapes
Medical Bandages
- Muslin Bandage Rolls
- Elastic Bandage Rolls
- Triangular Bandages
- Orthopedic Bandages
- Elastic Plaster Bandages
- Other Bandages

Medical Tapes And Bandages, Application Outlook (Revenue USD Million, 2018 – 2030)

Surgical Wound
Traumatic Wound
Ulcer
Sports Injury
Burn Injury
Other Injuries

Medical Tapes And Bandages, End-Use Outlook (Revenue USD Million, 2018 – 2030)

Hospitals
Ambulatory Surgery Centers
Clinics
Retail
Others

Medical Tapes And Bandages, Regional Outlook (Revenue, USD Million, 2018 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Market Share Insights

April 2019: Smith & Nephew PLC purchased Osiris Therapeutics, Inc. with the goal of speeding up the development of its medical bandages and tapes product line, thus boosting its client base and market reach.

Key Companies profiled:

Some prominent players in the global medical tapes and bandages market include:

Smith & Nephew PLC
Mölnlycke Health Care AB
Ethicon Inc. (JOHNSON & JOHNSON)
Medtronic
3M
Beiersdorf AG
Urgo Medical
Dynarex Corporation
Winner Medical Group, Inc.
McKesson Corporation
Cardinal Health
3L Medicinal Products Group
B. Braun Melsungen AG
Paul Hartmann AG

Order a free sample PDF of the Medical Tapes And Bandages Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Surgical Sealants And Adhesives Market: Heart Transplant Procedures is Expected To Contribute To The Growth

Surgical Sealants and Adhesives Industry Overview

The global surgical sealants and adhesives market size was valued at USD 1.82 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% from 2022 to 2030. Sealants and adhesives have evolved to become useful accompaniments in modern surgical procedures. They are widely preferred because of their safety, efficacy, and usability in repairing injured tissues and supporting wounds obtained during surgery. The pandemic caused by COVID-19 across the globe resulted in nationwide lockdowns and exerted pressure on the healthcare settings. According to the list provided by the American College of Surgeons, all dental, medical, or surgical procedures that are nonessential and elective in nature were postponed, except for medical emergencies.

Factors contributing to the growth of this market are the rising demand for surgical services and increasing concerns to reduce surgical wounds. Globally, the number of surgeries being undertaken has increased significantly. According to the WHO estimations, approximately, 235 million major surgical procedures are undertaken worldwide every year. Surgical procedures are normally accompanied by the risk of wound infection, excessive bleeding, or tissue damage. In addition, patients suffering from diabetes need to be extra cautious as the chances of complications during and post-surgery are significantly higher in their case.

As the volume of surgeries is increasing, extensive R&D activities focused on the widening applications of surgical sealants and adhesives are also rising. Traditional alternatives to surgical sealants are sutures and staples, which are expected to be replaced by surgical sealants and adhesives owing to their better wound closure capabilities with minimal blood loss. The sealants facilitate less painful operations and do not need removal. Currently, sealants are facing limited market growth owing to their high costs. In addition, strict regulatory approvals are creating substantial challenges in market growth.

Gather more insights about the market drivers, restrains and growth of the Global surgical sealants and adhesives market

Browse through Grand View Research’s Medical Devices Industry Research Reports.

Buccal Drug Delivery Systems Market – The global buccal drug delivery systems market size was valued at USD 2.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 9.2% from 2021 to 2028.
Dental Articulators Market – The global dental articulators market size was valued at USD 126.1 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.1% from 2021 to 2028.

Surgical Sealants And Adhesives Market Segmentation

Grand View Research has segmented the global surgical sealants and adhesives market on the basis of type, application, and region:

Surgical Sealants And Adhesives Type Outlook (Revenue, USD Million, 2018 – 2030)

Natural or Biological Adhesives and Sealants
- Fibrin Sealants
- Collagen Based Adhesives
- Gelatin Based Adhesives
Synthetic and Semi-synthetic Adhesives and Sealants
- Cyanoacrylates
- Polymeric Hydrogels
- Urethane Based Adhesives

Surgical Sealants And Adhesives Application Outlook (Revenue, USD Million, 2018 – 2030)

Central Nervous System
Cardiovascular
General Surgery
Orthopedic
Pulmonary
Urology
Ophthalmology
Others

Surgical Sealants And Adhesives Regional Outlook (Revenue, USD Million, 2018 – 2030)

North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)

Key Companies profiled:

Some prominent players in the global surgical sealants and adhesives market include:

Baxter International, Inc.
CryoLife, Inc.
C.R. Bard, Inc.
Medtronic PLC
B. Braun Melsungen AG
Cohera Medical, Inc.
Ethicon, Inc. [J&J]
Mallinckrodt plc
Cardinal Health
Integra LifeSciences Holdings Corporation

Order a free sample PDF of the Surgical Sealants And Adhesives Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Europe Orthopedic Navigation Systems Market Size, Share & Trends Analysis Report 2022 – 2030

Europe Orthopedic Navigation System Industry Overview

The Europe orthopedic navigation systems market size was valued at USD 634.3 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 13.9% from 2022 to 2030. Rising incidences of osteoarthritis and demand for minimally invasive surgeries for joint replacement surgery are expected to boost the demand for surgical navigation systems over the forecast period. Rising expenditure on healthcare, awareness about computer-assisted surgical navigation systems, and adoption of these techniques are some factors expected to contribute to market growth in the forthcoming years.

The market has been adversely impacted by the COVID-19 lockdown scenario. The COVID-19 outbreak negatively impacted the elective surgical procedure demand and thereby restricted the growth of the market in Europe. Disruption in the supply chain, inter-country travel restrictions, and slow economic growth resulted in a decline from previous years. As the restriction on elective surgeries lifted post lockdown, the demand for orthopedic navigation systems is set to rise. Orthopedic clinics started with a limited number of elective procedures as the COVID-19 cases began decreasing, which is expected to propel the market growth.

Gather more insights about the market drivers, restrains and growth of the Europe Orthopedic Navigation System market

The European Commission estimates around 20% of the population to be aged above 60 years in 2025. Women are more prone to degenerative joint disorders as compared to men post the age of 50. The total age dependency ratio in Europe is expected to rise to 77.9% by 2080 and the age dependency ratio in 28 EU countries is projected to increase to around 51%. The growing geriatric and obese population prone to hip fractures and degenerative joint disorders is anticipated to create growth opportunities for orthopedic navigations systems in near future.

Browse through Grand View Research’s Medical Devices Industry Research Reports.

Nephrostomy Devices Market – The global nephrostomy devices market size was valued at USD 940.26 million in 2018 and is anticipated to expand at a CAGR of 7.8% from 2019 to 2026. Increasing cases of kidney stone disorder, a rise in demand for minimally invasive surgical procedures, and increased awareness about the product are a few factors driving the market.
Cranial Implants Market – The global cranial implants market size was valued at USD 991.80 million in 2018 and is anticipated to expand at a CAGR of 6.4% by 2026. Increasing prevalence of neurological diseases, injuries, wounds, and road accidents coupled with rising awareness among professionals is anticipated to propel the growth.

Europe Orthopedic Navigation Systems Market Segmentation

Grand View Research has segmented the Europe orthopedic navigation systems market based on application, end-use, and country:

Europe Orthopedic Navigation Systems Application Outlook (Revenue, USD Million, 2017 – 2030)

Knee
Hip
Spine

Europe Orthopedic Navigation Systems End-use Outlook (Revenue, USD Million, 2017 – 2030)

Hospitals
Ambulatory Surgical Centers

Key Companies profiled:

Some of the prominent players in the Europe orthopedic navigation systems market include:

B. Braun Melsungen AG
Stryker
Medtronic
Brainlab AG
Johnson & Johnson Services, Inc. (DePuy Synthes)
Zimmer Biomet
MicroPort Medical
Orthokey Italia SRL.
Amplitude

Order a free sample PDF of the Europe Orthopedic Navigation System Market Intelligence Study, published by Grand View Research.

About Grand View Research

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com